Zota Health Care Limited (NSE:ZOTA)
India · Delayed Price · Currency is INR 1,366.20
-7.40 (-0.54%)
Feb 18, 2026, 1:23 PM IST
Zota Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 4,728 | 2,930 | 1,805 | 1,400 | 1,312 | 1,068 |
Other Revenue | - | - | - | 7.94 | 0.77 | 3.98 |
| 4,728 | 2,930 | 1,805 | 1,408 | 1,313 | 1,072 | |
Revenue Growth (YoY) | 92.70% | 62.32% | 28.23% | 7.22% | 22.47% | 12.62% |
Cost of Revenue | 2,034 | 1,385 | 971.65 | 835.11 | 867.29 | 733.65 |
Gross Profit | 2,694 | 1,545 | 833.24 | 572.41 | 445.41 | 338.21 |
Selling, General & Admin | 1,636 | 998.59 | 371.74 | 212.65 | 159.4 | 216.07 |
Other Operating Expenses | 924.31 | 593.72 | 385.95 | 278.46 | 137.26 | 111.75 |
Operating Expenses | 3,258 | 2,024 | 958.55 | 610.68 | 333.37 | 359.5 |
Operating Income | -564.58 | -479.32 | -125.31 | -38.27 | 112.05 | -21.29 |
Interest Expense | -136.87 | -89.74 | -41.99 | -24.86 | -2.58 | -0.5 |
Interest & Investment Income | 17.09 | 17.09 | 9.37 | 8.82 | 13.16 | 7.2 |
Currency Exchange Gain (Loss) | 2.56 | 2.56 | 1.94 | 2.37 | 2.3 | 1.15 |
Other Non Operating Income (Expenses) | 14.57 | -17.06 | -5.64 | -0.36 | -0.58 | -0.5 |
EBT Excluding Unusual Items | -667.23 | -566.48 | -161.63 | -52.29 | 124.35 | -13.94 |
Merger & Restructuring Charges | -7.81 | -7.81 | - | - | - | - |
Gain (Loss) on Sale of Assets | -0.08 | -0.08 | - | - | - | - |
Other Unusual Items | -2.07 | -2.07 | - | 5.38 | - | 10.29 |
Pretax Income | -677.2 | -576.44 | -161.63 | -46.91 | 124.35 | -3.65 |
Income Tax Expense | 47.84 | -9.06 | -18.15 | 10.82 | 35.27 | -1.57 |
Earnings From Continuing Operations | -725.04 | -567.39 | -143.48 | -57.73 | 89.08 | -2.09 |
Minority Interest in Earnings | -1.54 | 3.41 | - | - | - | - |
Net Income | -726.58 | -563.98 | -143.48 | -57.73 | 89.08 | -2.09 |
Net Income to Common | -726.58 | -563.98 | -143.48 | -57.73 | 89.08 | -2.09 |
Shares Outstanding (Basic) | 30 | 27 | 26 | 25 | 25 | 25 |
Shares Outstanding (Diluted) | 30 | 27 | 26 | 25 | 25 | 25 |
Shares Change (YoY) | 12.89% | 6.33% | 1.93% | 1.11% | 1.32% | - |
EPS (Basic) | -24.13 | -20.68 | -5.59 | -2.29 | 3.58 | -0.09 |
EPS (Diluted) | -24.13 | -20.68 | -5.59 | -2.29 | 3.58 | -0.09 |
Free Cash Flow | - | -959.42 | -226.94 | -145.05 | 100.84 | -28.18 |
Free Cash Flow Per Share | - | -35.18 | -8.85 | -5.76 | 4.05 | -1.15 |
Dividend Per Share | - | 1.000 | 1.000 | 1.000 | 1.500 | 1.000 |
Dividend Growth | - | - | - | -33.33% | 50.00% | - |
Gross Margin | 56.97% | 52.73% | 46.17% | 40.67% | 33.93% | 31.55% |
Operating Margin | -11.94% | -16.36% | -6.94% | -2.72% | 8.54% | -1.99% |
Profit Margin | -15.37% | -19.25% | -7.95% | -4.10% | 6.79% | -0.19% |
Free Cash Flow Margin | - | -32.75% | -12.57% | -10.31% | 7.68% | -2.63% |
EBITDA | -360.72 | -336.18 | -63.1 | 2.83 | 140.75 | 9.61 |
EBITDA Margin | -7.63% | -11.47% | -3.50% | 0.20% | 10.72% | 0.90% |
D&A For EBITDA | 203.85 | 143.15 | 62.21 | 41.1 | 28.7 | 30.9 |
EBIT | -564.58 | -479.32 | -125.31 | -38.27 | 112.05 | -21.29 |
EBIT Margin | -11.94% | -16.36% | -6.94% | -2.72% | 8.54% | -1.99% |
Effective Tax Rate | - | - | - | - | 28.37% | - |
Revenue as Reported | 4,780 | 2,950 | 1,816 | 1,419 | 1,328 | 1,080 |
Advertising Expenses | - | 121.52 | 62.27 | 78.95 | 50.1 | 115.31 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.